We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+4.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.79B
AUM Growth
-$730M
Cap. Flow
-$661M
Cap. Flow %
-23.73%
Top 10 Hldgs %
39.61%
Holding
2,225
New
423
Increased
362
Reduced
424
Closed
673
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRHC
851
DELISTED
Cohn Robbins Holdings Corp.
CRHC
$298K 0.01%
30,000
-338,683
-92% -$3.28M
CNO icon
852
CNO Financial Group
CNO
$5.12B
$297K 0.01%
+16,525
New +$306K
COP icon
853
ConocoPhillips
COP
$148B
$297K 0.01%
2,901
-34,453
-92% -$3.44M
TPL icon
854
Texas Pacific Land
TPL
$24.2B
$297K 0.01%
+1,503
New +$289K
MTG icon
855
MGIC Investment
MTG
$6.21B
$296K 0.01%
23,105
-10,237
-31% -$143K
HOLI
856
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$294K 0.01%
+17,183
New +$287K
APH icon
857
Amphenol
APH
$207B
$293K 0.01%
+8,748
New +$318K
TOL icon
858
Toll Brothers
TOL
$14B
$293K 0.01%
+6,986
New +$324K
BP icon
859
BP
BP
$110B
$292K 0.01%
10,225
EW icon
860
Edwards Lifesciences
EW
$53B
$292K 0.01%
+3,533
New +$340K
NXDT
861
NexPoint Diversified Real Estate Trust
NXDT
$245M
$292K 0.01%
23,300
-9,400
-29% -$146K
IIM icon
862
Invesco Value Municipal Income Trust
IIM
$595M
$291K 0.01%
25,290
+14,490
+134% +$191K
SLB icon
863
SLB Ltd
SLB
$78.9B
$291K 0.01%
8,092
+838
+12% +$30.4K
YI
864
111 Inc
YI
$36.1M
$291K 0.01%
+10,840
New +$292K
BNR
865
Burning Rock Biotech
BNR
$115M
$290K 0.01%
12,142
+6,442
+113% +$208K
LAZ icon
866
Lazard
LAZ
$4.16B
$290K 0.01%
9,105
-16,237
-64% -$584K
TKR icon
867
Timken Company
TKR
$8.77B
$290K 0.01%
4,919
-962
-16% -$59.7K
CPAY icon
868
Corpay
CPAY
$26.3B
$290K 0.01%
1,644
-1,251
-43% -$268K
BMI icon
869
Badger Meter
BMI
$3.95B
$289K 0.01%
3,127
-1,438
-32% -$133K
AVT icon
870
Avnet
AVT
$7.99B
$288K 0.01%
7,983
-7,507
-48% -$323K
TARS icon
871
Tarsus Pharmaceuticals
TARS
$2.97B
$288K 0.01%
16,821
-2,228
-12% -$35.4K
PGR icon
872
Progressive
PGR
$124B
$287K 0.01%
2,468
-1,303
-35% -$157K
GHIXU
873
DELISTED
Gores Holdings IX, Inc. Unit
GHIXU
$287K 0.01%
29,107
-1,000,000
-97% -$9.86M
TPC
874
Tutor Perini Cor
TPC
$5.18B
$286K 0.01%
+51,827
New +$393K
HTBK
875
DELISTED
Heritage Commerce
HTBK
$284K 0.01%
25,070
+1,198
+5% +$13.8K

Similar funds

Prelude Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Prelude Capital Management held 2,225 positions worth $2.79B, down 21% from $3.52B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management withdrew a net $661M in Q3 2022, closing 673 positions and reducing 424 holdings. Its most notable exit was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $30.7M.

  • Prelude Capital Management's largest Q3 2022 buy was KKR Acquisition Holdings I Corp.: 3,123,025 shares worth $30.7M.
  • Prelude Capital Management added most to Twitter, Inc. in Q3 2022, an estimated $23.5M increase.
  • Prelude Capital Management's biggest Q3 2022 reduction was Lockheed Martin, cutting an estimated $83M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q3 2022, selling an estimated $43.2M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $2.79B portfolio in Q3 2022.
  • Prelude Capital Management opened 423 new positions and closed 673 in Q3 2022.
  • Prelude Capital Management's portfolio value fell 21% quarter-over-quarter to $2.79B.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.